Results 51 to 60 of about 106,049,057 (196)
Current clinical application of serum biomarkers to detect and monitor ovarian cancer – update
In recent decades many potential serum biomarkers have been assessed in the diagnosis of ovarian cancer. Except cancer antigen 125 (CA125) and human epididymis protein 4 (HE4), none of them have been applied to everyday clinical practice.
Łukasz Janas, Ewa Kalinka, Marek Nowak
doaj +1 more source
A first single‐cell atlas of human orchitis reveals coordinated germ‐cell loss, somatic niche dysfunction, and immune‐metabolic remodeling. Aberrant SREBP2 activation in testicular somatic cells emerges as a central pathogenic node, while Fatostatin‐mediated inhibition of the SREBP pathway improves spermatogenesis, fibrosis, and lipid accumulation in a
Yanlin Tang +16 more
wiley +1 more source
In Sertoli cells of iNOA testes, downregulation of FADS2 activates STING, promoting collagen deposition and peritubular fibrosis while increasing germ‐cell susceptibility to necroptosis. Supplementation with FADS2‐derived PUFAs (GLA and DHA) inhibits STING, alleviates collagen accumulation, and facilitates the recovery of spermatogenesis.
Jiajing Lin +15 more
wiley +1 more source
Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up
The addition of human epididymis protein 4 (HE4) to carbohydrate antigen 125 (CA125) in ovarian cancer (OC) assessment has been proposed. We compared the clinical value of biomarker changes in a prospective series of patients undergoing OC ...
S. Ferraro +16 more
core +1 more source
Background: Endometrial cancer is the most common pelvic gynecological cancer in France. The most frequent symptom is post-menopausal bleeding and is one of the primary reasons for consultation in gynecological emergencies. The treatment is very codified
Manon Degez +11 more
doaj +1 more source
Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer
The purpose of this study was to evaluate the prognostic significance of serum human epididymis protein 4 (HE4) level in patients with epithelial ovarian cancer.A total of 78 women diagnosed with a pelvic mass and operated on in our institute comprised our cohort.
Jiheum, Paek +7 more
openaire +3 more sources
Metformin preconditioning enhances the migratory and therapeutic efficacy of adipose‐derived mesenchymal stem cells, promoting remyelination in a cuprizone‐induced mouse model. This effect is mediated by decorin‐driven modulation of the TGF‐β/CTGF signaling axis and extracellular matrix remodeling.
Fatemeh Taghizadeh +5 more
wiley +1 more source
Background The interaction between human epididymis protein 4 (HE4) and annexin A2 (Annexin A2) has been found in ovarian cancer. However, it is dimness whether the interaction exists in other malignant tumors. Methods Real-time PCR, western blotting and
Jing Wang +9 more
doaj +1 more source
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid +4 more
wiley +1 more source
Primary chemotherapy treatment response monitoring in advanced epithelial ovarian cancer (EOC) is currently based on CT-imaging and serum CA125 values. Serum HE4 profile during first line chemotherapy has not been previously studied. We evaluated the HE4
Tuulia Vallius +6 more
doaj +1 more source

